Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-69954981 |
| Mobile: | 15666777973 |
| E-mail: | dwyane.wang@boyuanpharm.com |
| QQ: | 327786186 |
| Skype: | Chat Now! |
| Address: | NO.12 TAIXING EAST STREET, JIBEI ECONOMIC DEVELOPMENT ZONE, JIYANG DISTRICT,JINAN CITY, 251400, SHANDONG,CHINA |
|
We are one of the well-known Chinese manufacturers of key Active Pharmaceutical Ingredients (APIs) and Intermediates with 20 years of experience and a presence in 20+ countries in the pharma sector. At Boyuan, we are committed to providing high-quality products and services with a team of experienced and qualified experts in R&D, QA, QC, and Manufacturing functions.
Formerly known as “Jinan Boyuan Chemical Co., Ltd” and “Shandong Boyuan Chemical Co., Ltd,” Boyuan was founded in June 2001, and we obtained the Drug Manufacturing License in January 2012. Currently, Boyuan operates two manufacturing plants located in Jiyang and Yucheng, Shandong, China. Covering an area of 30,000㎡, the Jiyang plant consists of 6 workshops with complete facilities and support functions. The Yucheng plant covers an area of 106,668㎡ and includes 12 workshops with complete facilities and public utilities, including a quality inspection center, warehousing, purified water preparation center, power distribution, boiler, sewage disposal, tank farm, and other auxiliary facilities. Both plants are established in line with the GMP standard, adhering to a strict quality management system, and conforming to international standards.
Boyuan is dedicated to producing anti-cancer, anti-tumor, anti-fungal, and other APIs and Intermediates with a team of experienced and qualified employees. We are devoted to technology innovation, extraordinary product quality and pursuing an excellent and responding customer service in a global vision.
|
|
| Product Name | MF | CAS | Details |
|---|
| 4-Amino-3-chlorophenol hydrochloride | C6H7Cl2NO | 52671-64-4 | Details |
| Fluorocytosine | C4H4FN3O | 2022-85-7 | Details |
| 2-(tert-Butoxycarbonylamino)thiazole-5-carboxylic acid | C9H12N2O4S | 302964-02-9 | Details |
| Miriplatin | C34H66N2O4Pt | 141977-79-9 | Details |
| 4-fluoro-2-Methoxy-5-nitroaniline | C7H7FN2O3 | 1075705-01-9 | Details |
| 2-Formylfuran-5-boronic acid | C5H5BO4 | 27329-70-0 | Details |
| Potassium hex achloroplatinate(IV) | Cl6KPt- | 16921-30-5 | Details |
| 4-Chloro-6-iodoquinazoline | C8H4ClIN2 | 98556-31-1 | Details |
| N. N, N '- trimethylethylenediamine | C5H14N2 | 142-25-6 | Details |
| 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro- | C25H29N7O3 | 1421372-67-9 | Details |
| 4-Chloro-7-methoxyquinoline-6-carboxamide | C11H9ClN2O2 | 417721-36-9 | Details |
| 2-Amino-5-bromopyridine | C5H5BrN2 | 1072-97-5 | Details |
| N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine | C20H16FN5O3 | 1421372-94-2 | Details |
| 2,3-DIMETHOXYBENZONITRILE | C9H9NO2 | 2024-83-1 | Details |
| Potassium tetrachloroplatinate(Ⅱ) | Cl4KPt- | 10025-99-7 | Details |
| Mutated EGFR-IN-1 | C25H31N7O | 1421372-66-8 | Details |
| Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
| 3,4-Dihydroxybenzonitrile | C7H5NO2 | 17345-61-8 | Details |
| 3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene | C13H9ClFNO3 | 443882-99-3 | Details |
| 1-Boc-4-(6-nitropyridin-3-yl)piperazime | C14H20N4O4 | 571189-16-7 | Details |
| 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxylic acid methyl ester | C12H11NO4 | 205448-65-3 | Details |
| N-[3-Chloro-4-(3-fluorobenzyloxy) phenyl]-6-iodoquinazolin-5-amine | C21H14ClFIN3O | 231278-20-9 | Details |
| N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea | C10H11ClN2O2 | 796848-79-8 | Details |
| Nedaplatin | C2H6N2O3Pt | 95734-82-0 | Details |
| Trans-1,2-diaminocyclohexane | C6H14N2 | 1121-22-8 | Details |
| 3-(2-chloropyriMidin-4-yl)-1-Methylindole | C13H10ClN3 | 1032452-86-0 | Details |
| 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile | C13H16N2O6 | 236750-65-5 | Details |
| 1,2,3-triacetyl-5-deoxy-β-D-Ribose | C11H16O7 | 62211-93-2 | Details |
| (2-Chloro-4-hydroxyphenyl)carbamic acid phenyl ester | C13H10ClNO3 | 796848-80-1 | Details |
| 6-Iodo-4-hydroxyquinazoline | C8H5IN2O | 16064-08-7 | Details |
| 2-Aminoethylmethylsulfone hydrochloride | C3H10ClNO2S | 104458-24-4 | Details |
| Dicydoplatin | C12H18N2O8Pt | 287402-09-9 | Details |
| 5-Bromo-2-nitropyridine | C5H3BrN2O2 | 39856-50-3 | Details |
| 3,4-Bis(2-methoxyethoxy)benzonitrile | C13H17NO4 | 80407-68-7 | Details |
| 5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde | C26H17ClFN3O3 | 231278-84-5 | Details |
| 3-Chloro-4-(3-fluorobenzyloxy)aniline | C13H11ClFNO | 202197-26-0 | Details |
| Tegafur | C8H9FN2O3 | 17902-23-7 | Details |
| 4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester | C16H17NO7 | 205448-64-2 | Details |
| Erlotinib | C22H23N3O4 | 183321-74-6 | Details |
| 4-Amino-3-chlorophenol | C6H6ClNO | 17609-80-2 | Details |
| 2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one | C13H14ClN3O | 1013916-37-4 | Details |
| 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | C11H10ClN3OS | 302964-24-5 | Details |
| Hexachloroplatinum(Ⅳ)Acid Hydrat | Cl6H2Pt | 16941-12-1 | Details |
| 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine | C13H16FN3O6 | 161599-46-8 | Details |
| 4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester | C12H10ClNO3 | 205448-66-4 | Details |
| N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-yrimidinyl)amino]-5-thiazolecarboxamide | C16H13Cl2N5OS | 302964-08-5 | Details |
| 5-Bromo-2-chloro-4-(cyclopentylamino)pyrimidine | C9H11BrClN3 | 733039-20-8 | Details |
| 2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile | C13H18N2O4 | 950596-58-4 | Details |
| 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate | C19H26FN3O8 | 162204-20-8 | Details |
| 1(3H)-Isobenzofuranone, 3-[(3-bromo-4-fluorophenyl)methylene]-, (3Z)- | C15H8BrFO2 | 1423030-14-1 | Details |
| N-(2-Pyrazinylcarbonyl)-L-phenylalanine | C14H13N3O3 | 114457-94-2 | Details |
| Trans-1,2-diamin ocyclohexane-N,,N’N’-tetraacetic acid | C14H24N2O9 | 123333-90-4 | Details |
| 2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile | C16H8FNO2 | 763114-25-6 | Details |
| 4-Bromo-2-fluoro-N-methylbenzamide | C8H7BrFNO | 749927-69-3 | Details |
| Cyclophosphamide monohydrate | C7H17Cl2N2O3P | 6055-19-2 | Details |
| 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid | C16H11FN2O3 | 763114-26-7 | Details |
| N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
| N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | C13H17FN2O3 | 1332524-01-2 | Details |
| Pemetrexed disodium INT-6; Pemetrexed Diacid; | C20H21N5O6 | 137281-23-3 | Details |
| Ifosfamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
| 3-(2-Chloroactyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide | C7H13Cl2N2O3P | 72578-71-3 | Details |
| 2-Chloro-4,6-dimethoxy-1,3,5-triazine | C5H6ClN3O2 | 3140-73-6 | Details |
| Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
| Diethyl L-glutamate hydrochloride | C9H18ClNO4 | 1118-89-4 | Details |
| Oteracil Potassium | C4H2KN3O4 | 2207-75-2 | Details |
| Pemetrexed disodium hemipenta hydrate | C20H24N5NaO7 | 357166-30-4 | Details |
| 3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid | C10H11O5P | 61260-15-9 | Details |
| Lenalidomide hemihydrate | C26H28N6O7 | 847871-99-2 | Details |
| Pemetrexed disodium INT-3;4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid Methyl Ester | C16H16N4O3 | 155405-80-4 | Details |
| Cisplatin | Cl2H6N2Pt | 15663-27-1 | Details |
| Carboplatin | C6H12N2O4Pt | 41575-94-4 | Details |
| Capecitabine | C15H22FN3O6 | 154361-50-9 | Details |
| 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide | C21H19ClN4O4 | 417716-92-8 | Details |
| Osimertinib | C28H33N7O2 | 1421373-65-0 | Details |
| Lenvatinib mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
| AZD-9291 mesylate | C29H37N7O5S | 1421373-66-1 | Details |
| 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | C13H13BrClN3O | 1016636-76-2 | Details |
| Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
| 3-Amino-2,6-piperidinedione hydrochloride | C5H9ClN2O2 | 24666-56-6 | Details |
| Methyl 2-bromomethyl-3-nitrobenzoate | C9H8BrNO4 | 98475-07-1 | Details |
| 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C27H34BrN7O3 | 571188-82-4 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | C13H11N3O5 | 827026-45-9 | Details |
| Zoledronic acid hydrate | C5H12N2O8P2 | 165800-06-6 | Details |
| Lapatinib ditosylate | C36H34ClFN4O7S2 | 388082-77-7 | Details |
| Lapatinib ditosylate monohydrate | C41H40ClFN4O11S3 | 388082-78-8 | Details |
| Dasatinib monohydrate | C22H28ClN7O3S | 863127-77-9 | Details |
| Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| Ethyl 2-aminothiazole-5-carboxylate | C6H8N2O2S | 32955-21-8 | Details |
| Pemetrexed disodium hepthydrate | C20H24N5NaO7 | 357166-29-1 | Details |
| Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
| Oxaliplatin | C8H12N2O4Pt | 61825-94-3 | Details |
| 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile | C9H3F3N2S | 143782-23-4 | Details |
| (1R,2R)-(-)-1,2- diaminocyclohexane acid | C6H14N2 | 20439-47-8 | Details |
| Pemetrexed disodium INT-4;4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-Benzoic Acid | C15H14N4O3 | 137281-39-1 | Details |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | C17H29BF3NO4 | 179324-87-9 | Details |
| Tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | C14H22N4O2 | 571188-59-5 | Details |
| Pemetrexed disodium INT-5;N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate | C31H37N5O9S | 165049-28-5 | Details |
| 4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester | C33H45N7O4 | 866084-31-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||